06/04/2020 12:00 AM EDT
Source: U.S. Government Accountability Office (GAO). Published: 6/4/2020. This two-page document provides information about infectious disease models, which can help guide policy decisions, such as how to allocate health care resources in response to COVID-19. Interpreting models requires understanding their purpose, limitations, and assumptions. (PDF)
06/04/2020 12:00 AM EDT
Source: U.S. Department of Health and Human Services (HHS). Published: 6/4/2020. This six-page document provides guidance that specifies what additional data must be reported to the Department of Health and Human Services (HHS) by laboratories along with coronavirus disease 2019 (COVID-19) test results. The guidance standardizes reporting to ensure that public health officials have access to comprehensive and nearly real-time data to inform decision-making in their response to COVID-19. (PDF)
06/02/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/2/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Elecsys IL-6. The Elecsys IL-6 is authorized for use in human serum and plasma specimens collected from patients with confirmed COVID-19 to identify severe inflammatory response by their healthcare provider to aid in determining the risk of intubation with mechanical ventilation, in conjunction with clinical findings and the results of other laboratory testing. (PDF)
06/01/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/1/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Gravity Diagnostics COVID-19 Assay. The Gravity Diagnostics COVID-19 Assay is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 infection by their healthcare provider or self-collected using a home collection kit specified in the test’s instructions for use. (PDF)
Fact Sheet for Healthcare Providers: Emergency Use of Impella RP System During the COVID-19 Outbreak
05/29/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/29/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Impella RP System. The Impella RP is authorized for emergency use in the hospital setting to provide temporary right ventricular support for up to 14 days in critical care patients with a body surface area ≥1.5 m2, who develop acute right heart failure or decompensation due to COVID-19 related complications, including pulmonary embolism (PE). (PDF)
05/21/2020 12:00 AM EDT
Source: American Academy of Pediatrics (AAP). Published: 5/21/2020. These Frequently Asked Questions, updated on May 21, 2020, provide initial guidance for the management of infants born to mothers with confirmed and suspected COVID-19. (PDF)
05/21/2020 12:00 AM EDT
Source: U.S. House of Representatives, Committee on Oversight and Reform. Published: 5/21/2020. The witnesses in this two-hour, 21-minute hearing of the Select Subcommittee on the Coronavirus Crisis were essential and frontline workers and their families, who discussed the dangers they face serving their communities during the COVID-19 pandemic and the need for government action to protect them. The essential workers described the health risks, financial hardships, and emotional impacts they have faced during the pandemic. (Video or Multimedia)
05/13/2020 12:00 AM EDT
Source: U.S. Government Accountability Office (GAO). Published: 5/13/2020. This 78-page report examines the extent to which the Department of Health and Human Services (HHS) has used infectious disease models to inform policy, planning, and resource allocation for public health decisions; the extent to which HHS has coordinated modeling efforts; steps HHS generally takes to assess model development and performance; and the extent to which HHS has addressed challenges related to modeling. (PDF)
04/29/2020 12:00 AM EDT
Source: Office of Inspector General [U.S. Department of Health and Human Services] (HHS OIG). Published: 4/29/2020. This 42-page report summarizes analysis of responses and documentation to determine the extent to which health care coalitions (HCCs) expanded their membership; to identify HCC benefits and challenges for coordinating with members; and to determine the extent to which the Assistant Secretary for Preparedness and Response requirements and guidance facilitate HCCs' and Health Preparedness Program awardees' ability to increase whole community preparedness. (PDF)
03/19/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/19/2020. This guidance will help child care programs, schools, and their partners understand how to help prevent the transmission of COVID-19 within child care and school communities and facilities. It also aims to help child care programs, schools, and partners react quickly should a case be identified. (Text)
No hay comentarios:
Publicar un comentario